Top 35 Lion Point Capital LP Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| PRAX | PRAXIS PRECISION MEDICINES I | 8.57% | 4.5K | $1.4M | +0.00%(+0) | $47.52(+570.22%) | 2026-03-31 | |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 7.52% | 67.5K | $1.3M | +0.00%(+0) | $27.19(-30.29%) | 2026-03-31 | |
| RPRX | ROYALTY PHARMA PLC | 6.14% | 21.4K | $1.0M | +0.00%(+0) | $35.65(+62.02%) | 2026-03-31 | |
| MIST | MILESTONE PHARMACEUTICALS IN | 5.83% | 820.0K | $976K | +8.61%(+65.00K) | $2.65(-50.22%) | 2026-03-31 | |
| GERN | GERON CORP | 5.15% | 578.0K | $861K | +0.00%(+0) | $2.57(-46.99%) | 2026-03-31 | |
| SNDX | SYNDAX PHARMACEUTICALS INC | 5.03% | 36.0K | $841K | +0.00%(+0) | $20.82(+4.81%) | 2026-03-31 | |
| ARDX | ARDELYX INC | 4.61% | 128.7K | $771K | +0.00%(+0) | $1.85(+185.04%) | 2026-03-31 | |
| FENC | FENNEC PHARMACEUTICALS INC | 4.13% | 112.4K | $691K | +0.00%(+0) | $8.73(+22.62%) | 2026-03-31 | |
| BNTC | BENITEC BIOPHARMA INC | 3.95% | 62.0K | $660K | +0.00%(+0) | $9.14(+44.70%) | 2026-03-31 | |
| SRPT | SAREPTA THERAPEUTICS INC | 3.71% | 28.5K | $620K | +0.00%(+0) | $20.40(-5.47%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +8.30% | +27.03% |
| Top 20 Holdings Unweighted | +9.76% | +32.25% |
Sign up free to track Lion Point Capital LP, compare funds side by side, and get alerts the moment positions change.